Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium
Ann Lismond(UCLouvain), Françoise Van Bambeke(UCLouvain), Te‐Din Huang(Medical University of Sofia), Patricia Schatt, Anne Dediste(Centre Hospitalier Universitaire de Saint-Pierre), Annelies De Bel(Universitair Ziekenhuis Brussel), Paul Jordens(Onze Lieve Vrouwziekenhuis Hospital), Sylviane Carbonnelle(UCLouvain), F. Verschuren(Cliniques Universitaires Saint-Luc), Jan Verhaegen(KU Leuven), Y. Glupczynski(University of Antwerp), Frédérique Jacobs(Université Libre de Bruxelles), Paul M. Tulkens(UCLouvain)
Cited by 11
Related Papers
Tackling antibiotic resistance
|Nature Reviews Microbiology|2011|1.1k
Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread
|Nature Microbiology|2019|817
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
|The Lancet|2007|689
Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study
|Clinical Infectious Diseases|2005|593
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium
|Clinical Microbiology and Infection|2007|575